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Abstract 
o-Phenylenediamines (OPDA) undergo smooth condensation with 4,6-di-O-benzyl- or 4,6-di-O-
acetyl- or 4,6-di-O-ethyl-2,3-dideoxy-aldehydo-D-erythro-trans-hex-2-enose derived from D-
glucal in the presence of 2 mol% of InCl3 under mild conditions to afford a new class of 1,5-
benzodiazepines in good yields. 
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Introduction 
 
Benzodiazepines have recently received great importance because of their wide range of 
therapeutic and pharmacological properties. Many members of diazepine family are nowadays 
widely used as anticonvulsant, antianxiety, analgesic, sedative, antidepressive, and hypnotic 
agents.1,2 Benzodiazepine derivatives also find commercial use as dyes for acrylic fibers3 and as 
anti-inflammatory agents.4 In addition, 1,5-benzodiazepines are key intermediates for the 
synthesis of various fused ring compounds such as triazolo-, oxadiazolo-, oxazino-, or furano-
benzodiazepines.5 As a result, various methods have been developed for the synthesis of 1,5-
benzodiazepines.6,7 Due to their wide range of biological, industrial and synthetic applications, 
the development of mild and efficient protocols continues to be a challenging endeavor in 
synthetic organic chemistry. In recent years, indium chloride has evolved as mild and water-
tolerant Lewis acid imparting high regio-, stereo- and chemoselectivity in various organic 
transformations.8 Compared to conventional Lewis acids, indium trichloride in particular has 
advantages of low catalyst loading, moisture stability and catalyst recycling. However, there 
have been no reports on the synthesis of diazepines from α,β-unsaturated sugar aldehyde and o-
phenylenediamines. 
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Results and Discussion 
 
In this article, we describe a novel and rapid approach for the synthesis of 1,5-benzodiazepines 
from o-phenylenediamines and 4,6-di-O-substituted-2,3-dideoxy-aldehydo-D-erythro-trans-hex-
2-enose9 using indium(III)chloride as a catalyst. Accordingly, treatment of o-phenylenediamine 1 
with 4,6-di-O-benzyl-2,3-dideoxy-aldehydo-D-erythro-trans-hex-2-enose 2 in the presence of 2 
mol% of InCl3 in ethanol at room temperature afforded 1,5-benzodiazepine 3a in 85% yield 
(Scheme 1). 
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Scheme 1 
 
The structure of the product 3a was established by using various solution NMR experiments 
like DQFCOSY, NOESY and HSQC. The HSQC spectrum showed that the presence of four CH2 
and eight CH’s in the product 3a. 
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Figure 1. Schematic diagram with long range nOes of 3a. 
 
In a similar manner, various substituted o-phenylenediamines such as 4-methyl-, 4,5-
dimethyl-, reacted rapidly with 4,6-di-O-benzyl-2,3-dideoxy-aldehydo-D-erythro-trans-hex-2-
enose to give the corresponding benzodiazepine derivatives (entries 1a-c Table 1). Other 
substrates such as 4,6-di-O-ethyl- and 4,6-di-O-acetyl-2,3-dideoxy-aldehydo-D-erythro-trans-
hex-2-enose gave the respective substituted 1,5-benzodiazepines in good yields under similar 
conditions (entries d-g, Table 1). All the products were characterized by 1H, 13C NMR, IR, and 
mass spectral analysis. The probable mechanism seems to be addition of amine to the 
unsaturated position of conjugated aldehyde, which is activated by indium trichloride. Thus the 
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initially formed Michael adduct may undergo cyclization with another amino group leading to 
the formation of diazepine (Scheme 2). 
 
NH2
NH2
OR
OH
ORH
OIn(III)
OR
OH
OR
NH
H
OIn(III)
NH2
OR
OH
ORH
NHOH
NH2
N
H
N
ORRO
OHInCl3
+ .. +
..
 
 
Scheme 2 
 
Among various acid catalysts such as CeCl3.7H2O, YbCl3, YCl3, and BiCl3 tested, indium 
trichloride was found to give the best results in terms of reaction rates and conversion. Further, 
we have carried out the experiments using various solvents such as water, ethanol, ionic liquid 
[bmim]BF4, acetonitrile and tetrahydrofuran. As a solvent, ethanol appeared to give the best 
results. The scope and generality of this process was illustrated with respect to various 
substituted diamines and unsaturated sugar aldehydes and the results are summarized in Table 1. 
 
 
Conclusions 
 
In summary, we have developed a mild, rapid and efficient method for the synthesis pure 1,5-
benzodiazepines through the condensation of sugar derived α,β-unsaturated-δ-hydroxyaldehydes 
with o-phenylenediamines using indium trichloride as the catalyst. The use of commercially 
available indium trichloride makes this method quite simple, more convenient and practical. It is 
entirely a novel protocol for the preparation of benzodiazepines in a single-step operation. 
 
 
Experimental Section 
 
General Procedures. IR spectra were recorded with a Perkin Elmer FTIR spectrophotometer. 1H 
NMR spectra were carried out using a Bruker Avance 300, Varian Unity 400 and Varian Unity 
500MHz spectrophotometer using TMS as an internal standard in CDCl3. Mass spectra were 
recorded on Micro mass VG Autospec M for FABMS mass spectrometers. Melting points for all 
the compounds were recorded on Electrothermal-9100 instrument. The progress of all the 
reactions was monitored by thin-layer chromatography (TLC) using glass plates precoated with 
silica gel 60F254 to a thickness of 0.25mm (Merck). Column chromatography was conducted by 
elution of columns with silica gel 60-120 mesh using ethyl acetate and hexane as eluents. 
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General synthetic procedure 
A mixture of o-phenylenediamine (1 mmol), α,β-unsaturated-δ-hydroxyaldehyde (1 mmol) and 
indium trichloride (0.02 mmol) in ethanol (10 mL) was stirred at room temperature for the 
appropriate time (Table 1). After completion of the reaction, as indicated by TLC, the reaction 
mixture was diluted with water and extracted by ethyl acetate (3x 10 mL). The combined organic 
extracts were dried over anhydrous Na2SO4, concentrated in vacuo and the resulting product was 
directly charged on small silica gel column and eluted with a mixture of ethyl acetate-hexane 
(1:9) to afford benzodiazepine. Spectral data for selected products. 
 
1,3-Di(benzyloxy)-1-(2,3-dihydro-1H-benzo[b][1,4]diazepin-3-yl)-(1S,2R)-propan-2-ol (3a). 
Pale yellow crystalline solid, m.p. 95-97 oC; IR (KBr): 3354, 2921, 1507, 1304, 1101, 742 cm-1; 
1H NMR (500 MHz, CDCl3): δ 2.07 (dt, JHa-Hb'=5.0 Hz, JHb-Hb'=14.3 Hz, JHb'-Hc=9.1 Hz, 1H, Hb'), 
2.33 (dd, JHb-Hc=3.6 Hz, JHb-Hb'=14.3 Hz, 1H, Hb), 3.56 (dd, JHc-Hd=3.1 Hz, JHd-He=9.8 Hz, 1H, 
Hd), 3.67 (dd, JHe-Hf=2.1 Hz, JHf-Hf'=10.5 Hz, 1H, Hf), 3.78 (dd, JHe-Hf'=4.0 Hz, JHf-Hf'=10.5 Hz, 
1H, Hf'), 3.80 (m, 1H, Hc), 4.16 (brs, 1H, NH), 4.56 (ABq, J=11.2 Hz, 2H, Hh and Hh'), 4.59 
(ABq, J=11.2 Hz, 2H, Hg and Hg'), 5.03 (ddd, JHe-Hf =2.1 Hz, JHe-Hf' =4.0 Hz, JHd-He=9.8 Hz, 1H, 
He), 5.08 (d, JHa-Hb'=5.0 Hz, 1H, Ha), 7.5-6.5 (m, 14H, Ar-H); 13C NMR (75 MHz, DMSO-d6): δ 
138.8, 138.5, 137.1, 135.9, 128.2, 128.1, 127.5, 127.2, 119.5, 118.6, 118.4, 117.5, 77.2, 76.2, 
72.2, 70.1, 69.4, 66.2, 47.1, 31.6; FABMS: m/z 415 (M+·) 367, 293, 277, 247, 173, 136, 115, 91, 
81, 69, 55; HRMS calcd for C26H27N2O3: 415.2021 found: 415.2015. 
1,3-Di(benzyloxy)-1-(7-methyl-2,3-dihydro-1H-benzo[b][1,4]diazepin-3-yl)-(1S,2R)- 
propan-2-ol (3b). Pale yellow crystalline solid, m.p. 62-64 oC; IR (KBr): 3356, 2917, 1597, 
1495, 1306, 1102, 807, 745 cm-1; 1H NMR (400 MHz, CDCl3): δ 2.05 (m, 1H), 2.16 (s, 3H), 2.31 
(dd, JHb-Hf =3.71 Hz, JHb-Hb'=14.8 Hz, 1H, Hb), 3.55 (dd, JHe-Hf=2.9 Hz, JHf-Hf'=9.6 Hz, 1H, Hf), 
3.66 (dd, JHe-Hf'=2.2 Hz, JHf-Hf'=9.6 Hz, 1H, Hf'), 3.75-3.80 (m, 2H, Hd and Hc), 4.1 (brs, 1H, 
NH), 4.56 (ABq, J=11.8 Hz, 2H, Hh and Hh'), 4.58 (ABq, J=11.8 Hz, 2H, Hg and Hg'), 5-5.05 
(m, 1H, He), 5.06-5.1 (d, JHa-Hb=3.71 Hz, 1H, Ha), 6.36-6.56 (m, 3H, Ar-H), 7.24-7.38 (m, 10H, 
Ar-H); 13C NMR (75 MHz, CDCl3): δ 138.6, 138.3, 136.1, 135.5, 133.6, 133.0, 130.1, 130.7, 
128.4, 128.2, 127.9, 127.6, 127.5, 121.8, 121.0, 120.1, 119.2, 118.3, 78.5, 73.4, 71.5, 69.7, 66.0, 
49.4, 49.2, 30.5, 20.4; FABMS: m/z 430 (M+·) 201, 189, 175, 133, 109, 91, 79, 69, 55; HRMS 
calcd for C27H30N2O3: 430.2256 found: 430.2243. 
1,3-Di(benzyloxy)-1-(7,8-dimethyl-2,3-dihydro-1H-benzo[b][1,4]diazepin-3-yl)-(1S,2R)- 
propan-2-ol (3c). Pale yellow crystalline solid, m.p. 60-61 oC; IR (KBr): 3374, 3028, 2919, 
2862, 1618, 1512, 1454, 1360, 1091, 1026, 866, 742, 697 cm-1; 1H NMR (400 MHz, CDCl3): δ 
2.05 (m, 1H), 2.16 (s, 6H), 2.31 (dd, JHb-Hc=3.71 Hz, JHb-Hb'=14.8 Hz, 1H, Hb), 3.55 (dd, JHe-
Hf=2.9 Hz, Hf- Hf'=9.6 Hz, 1H, Hf), 3.65 (dd, JHe-Hf'=2.2 Hz, JHf-Hf'=9.6 Hz, 1H, Hf'), 3.74-3.79 (m, 
2H, Hd and Hc), 4.1 (d, J=5.9 Hz, 1H, NH), 4.55 (ABq, J=11.8 Hz, 2H, Hh and Hh'), 4.59 (ABq, 
J=11.8 Hz, 2H, Hg and Hg'), 5.01 (ddd, JHe-Hf=1.48 Hz, JHe-Hf'=3.7 Hz, and JHd-He=9.6 Hz, 1H, 
He), 5.06 (t, JHa-Hb'=5.2 Hz, 1H, Ha), 6.33 (s, 1H, Ar-H), 6.37 (s, 1H, Ar-H), 7.23-7.39 (m, 10H, 
Ar-H); 13C NMR (75 MHz, CDCl3 ): δ 138.6, 138.3, 133.7, 133.1, 128.8, 128.3, 127.8, 127.6, 
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127.5, 127.4, 127.2, 120.9, 119.8, 78.5, 76.8, 73.4, 71.4, 69.7, 66.1, 49.0, 30.6, 18.6; FABMS: 
m/z 444 (M+·) 430, 203, 189, 173, 160, 154, 147, 136, 123, 109, 91, 79, 69; HRMS calcd for 
C28H32N2O3: 444.2412 found: 444.2403. 
1-(2,3-Dihydro-1H-benzo[b][1,4]diazepin-3-yl)-1,3-diethoxy-(1S,2R)-propan-2-ol (3d). Brow 
n crystalline solid, m.p.73-74 oC; IR (KBr): 3356, 2924, 2856, 1597, 1504, 1375, 1304, 1103, 
745 cm-1; 1H NMR (500 MHz, CDCl3): δ 1.20-1.35 (m, 6H), 2.05 (dt, J=5.0, 14.3 and 9.1 Hz, 
1H), 2.38 (dd, J=3.6 and 14.3 Hz, 1H), 3.30-3.78 (m, 8H), 3.80 (m, 1H), 4.15 (brs, 1H, NH), 
4.98 (ddd, J=2.1, 4.0 and 9.8 Hz, 1H), 5.07 (d, J=5.0 Hz, 1H), 6.58-6.80 (m, 4H, Ar-H); 13C 
NMR (75 MHz, CDCl3): δ 136.4, 135.6, 121.3, 120.5, 119.5, 118.4, 78.5, 69.9, 66.7, 65.9, 49.4, 
30.5, 29.6, 15.6, 15.0; FABMS: m/z 292 (M+·) 176, 146, 120, 91, 71, 57; HRMS calcd for 
C16H24N2O3: 292.1786 found: 292.1775. 
1,3-Diethoxy-1-(7-methyl-2,3-dihydro-1H-benzo[b][1,4]-diazepin-3-yl)-(1S,2R)-propan-2-ol 
(3e). Brown crystalline solid, m.p.68-69 oC; IR (KBr): 3356, 2924, 2856, 1597, 1504, 1375, 
1304, 1103, 745 cm-1; 1H NMR (500 MHz, CDCl3): δ 1.20-1.27 (m, 6H), 2.05 (dt, J=5.0, 14.3 
and 9.1 Hz, 1H), 2.17 (s, 3H), 2.35 (dd, J=3.6 and 9.8 Hz, 1H), 3.35-3.75 (m, 8H), 3.85 (m, 1H), 
4.10 (brs, 1H, NH), 4.95 (ddd, J=2.1, 4.0 and 9.8 Hz, 1H), 5.07 (d, J=4.5 Hz, 1H), 6.36-6.54 (m, 
3H, Ar-H); 13C NMR (75 MHz, CDCl3): δ 135.5, 133.8, 130.0, 121.7, 119.5, 119.2, 78.5, 76.5, 
69.9, 66.7, 65.9, 64.8, 49.2, 30.5, 20.4, 15.6, 15.0; FABMS: m/z 306 (M+·) 217, 203, 185, 175, 
165, 159, 133, 121, 107, 95, 69, 55; HRMS calcd for C17H26N2O3: 306.1943 found: 306.1932. 
1-(7,8-Dimethyl-2,3-dihydro-1H-benzo[b][1,4]diazepin-3-yl)-1,3-diethoxy-(1S,2R)-propan-
2-ol (3f). Brown crystalline solid, m.p. 56-58 oC; IR (KBr): 3354, 2972, 2922, 2865, 2361, 1615, 
1517, 1448, 1304, 1117, 1023, 869, 770 cm-1; 1H NMR (300 MHz, CDCl3): δ 1.24 (m, 6H), 2.06 
(dt, J=5.2, 14.2 and 8.9 Hz, 1H), 2.09 (d, J=2.4 Hz, 6H), 3.42-3.75 (m, 8H), 3.84 (m, 1H), 4.08 
(d, J=6.5 Hz, 1H), 4.12 (brs, 1H, NH), 4.95 (ddd, J=2.4, 4.2 and 6.5 Hz, 1H), 5.08 (d, J=4.9 Hz, 
1H), 6.33 (s, 1H, Ar-H), 6.41 (s, 1H, Ar-H); 13C NMR (75 MHz, CDCl3): δ 133.9, 133.4, 128.6, 
128.1, 121.0, 119.8, 78.7, 76.5, 70.1, 67.2, 65.3, 64.5, 49.5, 30.4, 29.1, 18.5, 15.3, 14.6; FABMS: 
m/z 320 (M+·) 173, 147, 119, 109, 95, 81, 69, 55; HRMS calcd for C18H28N2O3: 320.2099 found: 
320.2087. 
1-(2,3-Dihydro-1H-benzo[b][1,4]diazepin-3-yl)-2-hydroxy-3-methyl carboxyloxy-(1S,2R) -
propyl acetate (3g). Pale yellow crystalline solid, m.p. 89-90 oC; IR (KBr): 3376, 2924, 1736, 
1598, 1508, 1370, 1305, 1243, 1106, 1044, 748 cm-1; 1H NMR (300 MHz, CDCl3): δ 2.10 (s, 
3H), 2.1-2.2 (m, 1H), 2.13 (s, 3H), 2.39 (dd, J=3.2 and 14.7 Hz, 1H), 3.5 (brs, 1H, NH), 3.9 (bd, 
J=3.2 Hz, 1H), 4.10-4.20 (m, 2H), 4.37 (dd, J=4.1 and 12.3 Hz, 1H), 4.82 (dd, J=3.2 and 9.8 Hz, 
1H), 5.15 (t, J=4.9 Hz, 1H), 5.31 (ddd, J=2.4, 4.9 and 6.5 Hz, 1H), 6.56-6.8 (m, 4H, Ar-H); 13C 
NMR (75 MHz, CDCl3): δ 170.9, 170.1, 135.9, 135.3, 121.9, 121.3, 119.5, 118.8, 78.7, 70.8, 
63.5, 63.2, 49.7, 29.9, 21.0, 20.8; FABMS: m/z 320 (M+·) 219, 191, 154, 136, 91, 69, 57; HRMS 
calcd for C16H20N2O5: 320.1372 found: 320.1356. 
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Table 1. Synthesis of 1,5-diazepines from o-phenyldiamines and α,β-unsaturated aldehyde 
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Entry Diamine Aldehyde Producta Reaction time (min) Yield(%)b
1a 15 min 85
''
12 min 80
1b
''1c 10 min 78
1d
10 min 85
''
1e
12 min 79
''
15 min 751f
''
10 min 861g
 
a Products were characterized by 1H NMR, 13C NMR, IR and mass spectroscopy. 
b Yield refers to pure products after chromatography. 
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